Skip to content

Our technologies

small-molecules-logo-transp
gSmall Molecules Logo

Small molecules

Our multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology enables the creation of API nanoparticles directly from solution. The process can be applied to most small molecules, with a high success rate.

biologics-logo-transp

Biologics

Our biological nanoforming technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. It’s effectiveness has been demonstrated on proteins in the 1-150 kDa range, and it is capable of engineering particle sizes to specific requirements.

formulation-logo-transp

Formulation

Our experienced formulation development team designs and develops flexible dosage forms of nanoformed drug substances to meet preclinical and clinical development as well as life-cycle needs. Our dosage forms cover oral, parenteral, ophthalmic and inhaled therapies and more.

gmp-logo-transp

GMP Manufacturing

We have GMP manufacturing capabilities for the manufacture of nanoformed clinical-grade API’s (Active Pharmaceutical Ingredients) for our customers and partners.

HIGH POTENCY CAPABILITIES

Our GMP facility is currently able to handle compounds with OEL of 1 ug/m3 and above. In H1 2023, we are expanding this offering for highly-potent compound manufacturing to handle API with OEL down to 30 ng/m3

LATEST PRESS RELEASES & NEWS

To read more of our latest news and see our recent articles and videos, visit our media centre

Subscribe to hear the latest news about